Registry Outcomes Support Sirolimus-Eluting Stent Registry Outcomes Support Sirolimus-Eluting Stent

Compared with other frequently used newer-generation drug-eluting stents, the ultra-thin sirolimus-eluting device was associated with lower target lesion revascularization rates, new registry data suggest.Medscape Medical News

Source: Medscape Medical News Headlines - May 23, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news